Clinical trial

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

NCT00427206 · Denver Health and Hospital Authority, Other · Completed

Key facts

NCT number NCT00427206
Title Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing
Official title Hepatic Function Following Five Days of Therapeutic Dosing of Acetaminophen in Alcoholics
Lead sponsor Denver Health and Hospital Authority, Other
Collaborators McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Alcohol Related Disorders
Intervention type Drug
Interventions acetaminophen (4g/day), placebo
Enrollment 181
Start date Nov 1, 2004
Primary completion Dec 1, 2005
Completion Dec 1, 2005
First posted Jan 26, 2007
Last update posted Feb 9, 2009
Countries Canada, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies